IncobotulinumtoxinA Interactions
There are 120 drugs known to interact with incobotulinumtoxinA, along with 3 disease interactions. Of the total drug interactions, 25 are major, and 95 are moderate.
- View all 120 medications that may interact with incobotulinumtoxinA
- View incobotulinumtoxinA disease interactions (3)
Most frequently checked interactions
View interaction reports for incobotulinumtoxinA and the medicines listed below.
- Adriamycin (doxorubicin)
- Aleve (naproxen)
- Allegra (fexofenadine)
- Amitiza (lubiprostone)
- Aricept (donepezil)
- Armour Thyroid (thyroid desiccated)
- Ativan (lorazepam)
- Augmentin (amoxicillin / clavulanate)
- Bactrim (sulfamethoxazole / trimethoprim)
- Bactroban (mupirocin topical)
- Basaglar (insulin glargine)
- Belbuca (buprenorphine)
- Botox Cosmetic (onabotulinumtoxinA)
- BuSpar (buspirone)
- Bystolic (nebivolol)
- Calcium 600 D (calcium / vitamin d)
- Cerefolin NAC (multivitamin)
- Clinpro 5000 (fluoride topical)
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- Desyrel (trazodone)
- DOK (docusate)
- Ergotrate (ergonovine)
- Evening Primrose Oil (evening primrose)
- Fentanyl Transdermal System (fentanyl)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- Gammaplex (immune globulin intravenous)
- GenTeal (ocular lubricant ophthalmic)
- Lasix (furosemide)
IncobotulinumtoxinA disease interactions
There are 3 disease interactions with incobotulinumtoxinA which include:
More about incobotulinumtoxinA
- incobotulinumtoxinA consumer information
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: skeletal muscle relaxants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.